Escape from senescence boosts tumour growth
Nature - 20-Dec-2017Senescence is usually thought to be irreversible. Many anti-cancer therapies cause cancer-cell s...
Join the club for FREE to access the whole archive and other member benefits.
Study Director in division of Oncology/Immunology at preclinics
I am an experienced cancer research scientist with background in exploring mechanisms of hematological diseases, immune reactions to tumors, stem cell biology, gene expression patterns, epigenetic reprogramming, cancer signaling and cellular stress responses. I have thorough scientific knowledge and hands-on experience in discovery and validation of novel cancer treatments, based on targeting signaling mediators, metabolic conditioning or immunomodulation. I am skilled in team leadership, project planning and coordination, as well as presentation of results and scientific strategies to different audiences.
My mission is to use the emerging knowledge to explore and design precision oncology approaches which tackle the current limitations of cancer therapies.
Visit website: https://mkfz.charite.de/en/metas/person_detail/person/address_detail/milanovic/
See also: preclinics - Drug development, drug delivery formulations and medical devices company
Details last updated 16-Apr-2020
Senescence is usually thought to be irreversible. Many anti-cancer therapies cause cancer-cell s...